GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Akdital (CAS:AKT) » Definitions » Current Deferred Revenue

Akdital (CAS:AKT) Current Deferred Revenue : MAD0 Mil (As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Akdital Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Akdital's current deferred revenue for the quarter that ended in Jun. 2023 was MAD0 Mil.

Akdital Current Deferred Revenue Historical Data

The historical data trend for Akdital's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akdital Current Deferred Revenue Chart

Akdital Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Current Deferred Revenue
- - - -

Akdital Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Current Deferred Revenue Get a 7-Day Free Trial - - - - -

Akdital Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Akdital's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Akdital (CAS:AKT) Business Description

Traded in Other Exchanges
N/A
Address
258 Route de l’Oasis, Casablanca, MAR, 20250
Akdital operates private healthcare clinics. The company offers healthcare services such as cardiac surgery, neurosurgery, oncology, radiotherapy, intensive care, and neonatal care, providing patients with comprehensive care according to international standards.

Akdital (CAS:AKT) Headlines

From GuruFocus

Everspan Group Announces Retirement of Wyatt Blackburn

By Business Wire Business Wire 11-29-2022

Ambac to Release Fourth Quarter 2022 Results on February 28, 2023

By Business Wire Business Wire 02-14-2023

Ambac to Release Second Quarter 2022 Results on August 8, 2022

By Business Wire Business Wire 07-26-2022

Ambac Announces a Board Change

By Business Wire Business Wire 02-28-2023

Xchange Benefits to host Experience Xchange educational symposium

By Business Wire Business Wire 05-25-2023

Ambac Names John Tatum Business Development Officer for Cirrata Group

By Business Wire Business Wire 01-31-2023